These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29378718)

  • 1. Clofazimine for Treatment of Extensively Drug-Resistant Pulmonary Tuberculosis in China.
    Wang Q; Pang Y; Jing W; Liu Y; Wang N; Yin H; Zhang Q; Ye Z; Zhu M; Li F; Liu P; Wu T; Chen W; Wu W; Qin Z; Qiu C; Deng Q; Xu T; Wang J; Guo R; Du Y; Wang J; Huang H; Chen X; Chu N
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29378718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clofazimine in the treatment of extensively drug-resistant tuberculosis with HIV coinfection in South Africa: a retrospective cohort study.
    Padayatchi N; Gopal M; Naidoo R; Werner L; Naidoo K; Master I; O'Donnell MR
    J Antimicrob Chemother; 2014 Nov; 69(11):3103-7. PubMed ID: 24986495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment Outcome of a Shorter Regimen Containing Clofazimine for Multidrug-resistant Tuberculosis: A Randomized Control Trial in China.
    Du Y; Qiu C; Chen X; Wang J; Jing W; Pan H; Chen W; Liu Y; Li C; Xi X; Yin H; Zeng J; Zhang X; Xu T; Wang Q; Guo R; Wang J; Pang Y; Chu N
    Clin Infect Dis; 2020 Aug; 71(4):1047-1054. PubMed ID: 31549147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clofazimine for the treatment of multidrug-resistant tuberculosis: prospective, multicenter, randomized controlled study in China.
    Tang S; Yao L; Hao X; Liu Y; Zeng L; Liu G; Li M; Li F; Wu M; Zhu Y; Sun H; Gu J; Wang X; Zhang Z
    Clin Infect Dis; 2015 May; 60(9):1361-7. PubMed ID: 25605283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic review of clofazimine for the treatment of drug-resistant tuberculosis.
    Gopal M; Padayatchi N; Metcalfe JZ; O'Donnell MR
    Int J Tuberc Lung Dis; 2013 Aug; 17(8):1001-7. PubMed ID: 23541151
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Pang Y; Zong Z; Huo F; Jing W; Ma Y; Dong L; Li Y; Zhao L; Fu Y; Huang H
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment outcomes of pre- and extensively drug-resistant tuberculosis in Johannesburg, South Africa.
    Nkurunziza J; Karstaedt AS; Louw R; Padanilam X
    Int J Tuberc Lung Dis; 2018 Dec; 22(12):1469-1474. PubMed ID: 30606319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro synergistic activity of clofazimine and other antituberculous drugs against multidrug-resistant Mycobacterium tuberculosis isolates.
    Zhang Z; Li T; Qu G; Pang Y; Zhao Y
    Int J Antimicrob Agents; 2015 Jan; 45(1):71-5. PubMed ID: 25459737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study.
    Borisov SE; Dheda K; Enwerem M; Romero Leyet R; D'Ambrosio L; Centis R; Sotgiu G; Tiberi S; Alffenaar JW; Maryandyshev A; Belilovski E; Ganatra S; Skrahina A; Akkerman O; Aleksa A; Amale R; Artsukevich J; Bruchfeld J; Caminero JA; Carpena Martinez I; Codecasa L; Dalcolmo M; Denholm J; Douglas P; Duarte R; Esmail A; Fadul M; Filippov A; Davies Forsman L; Gaga M; Garcia-Fuertes JA; García-García JM; Gualano G; Jonsson J; Kunst H; Lau JS; Lazaro Mastrapa B; Teran Troya JL; Manga S; Manika K; González Montaner P; Mullerpattan J; Oelofse S; Ortelli M; Palmero DJ; Palmieri F; Papalia A; Papavasileiou A; Payen MC; Pontali E; Robalo Cordeiro C; Saderi L; Sadutshang TD; Sanukevich T; Solodovnikova V; Spanevello A; Topgyal S; Toscanini F; Tramontana AR; Udwadia ZF; Viggiani P; White V; Zumla A; Migliori GB
    Eur Respir J; 2017 May; 49(5):. PubMed ID: 28529205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and treatment outcome of extensively drug-resistant tuberculosis plus additional drug resistance from the National Clinical Center for Tuberculosis in China: A five-year review.
    Pang Y; Lu J; Huo F; Ma Y; Zhao L; Li Y; Liang Q; Chu N; Gao M; Huang H
    J Infect; 2017 Nov; 75(5):433-440. PubMed ID: 28804028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating children for drug-resistant tuberculosis in Tajikistan with Group 5 medications.
    Swaminathan A; du Cros P; Seddon JA; Quinnell S; Bobokhojaev OI; Dusmatova Z; Achar J
    Int J Tuberc Lung Dis; 2016 Apr; 20(4):474-8. PubMed ID: 26970156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Old antibiotics for emerging multidrug-resistant/extensively drug-resistant tuberculosis (MDR/XDR-TB).
    Brouqui P; Quenard F; Drancourt M
    Int J Antimicrob Agents; 2017 May; 49(5):554-557. PubMed ID: 28336312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clofazimine improves clinical outcomes in multidrug-resistant tuberculosis: a randomized controlled trial.
    Duan H; Chen X; Li Z; Pang Y; Jing W; Liu P; Wu T; Cai C; Shi J; Qin Z; Yin H; Qiu C; Li C; Xia Y; Chen W; Ye Z; Li Z; Chen G; Wang S; Liu Y; Chu L; Zhu M; Xu T; Wang Q; Wang J; Du Y; Wang J; Chu N; Xu S
    Clin Microbiol Infect; 2019 Feb; 25(2):190-195. PubMed ID: 30036672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy, safety and tolerability of linezolid for the treatment of XDR-TB: a study in China.
    Tang S; Yao L; Hao X; Zhang X; Liu G; Liu X; Wu M; Zen L; Sun H; Liu Y; Gu J; Lin F; Wang X; Zhang Z
    Eur Respir J; 2015 Jan; 45(1):161-70. PubMed ID: 25234807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No in vitro synergistic effect of bedaquiline combined with fluoroquinolones, linezolid, and clofazimine against extensively drug-resistant tuberculosis.
    Pang Y; Jing W; Lu J; Zong Z; Huo F; Dong L; Dai G; Li Y; Huang H; Chu N
    Diagn Microbiol Infect Dis; 2019 Aug; 94(4):361-364. PubMed ID: 30876684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-related treatment outcomes in South African patients prescribed clofazimine for drug-resistant tuberculosis.
    Misra N; Padayatchi N; Naidoo P
    S Afr Med J; 2020 Dec; 111(1):61-67. PubMed ID: 33404008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clofazimine in the treatment of multidrug-resistant tuberculosis.
    Xu HB; Jiang RH; Xiao HP
    Clin Microbiol Infect; 2012 Nov; 18(11):1104-10. PubMed ID: 22192631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis.
    Pym AS; Diacon AH; Tang SJ; Conradie F; Danilovits M; Chuchottaworn C; Vasilyeva I; Andries K; Bakare N; De Marez T; Haxaire-Theeuwes M; Lounis N; Meyvisch P; Van Baelen B; van Heeswijk RP; Dannemann B;
    Eur Respir J; 2016 Feb; 47(2):564-74. PubMed ID: 26647431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of MDR/XDR-TB patients treated with linezolid: experience in Thailand.
    Roongruangpitayakul C; Chuchottaworn C
    J Med Assoc Thai; 2013 Oct; 96(10):1273-82. PubMed ID: 24350407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensively drug-resistant tuberculosis in california, 1993-2006.
    Banerjee R; Allen J; Westenhouse J; Oh P; Elms W; Desmond E; Nitta A; Royce S; Flood J
    Clin Infect Dis; 2008 Aug; 47(4):450-7. PubMed ID: 18616396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.